Notably, epidemiological studies have demonstrated an association between ANGPTL8 and metabolic diseases (17–19), including hepatic steatosis; thus, posing it as a potential biomarker for diagnosis and monitoring. Here, ANGPTL8 is linked to fatty liver disease.